ALVOTECH |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.92 USD | +0.32% |
|
-2.18% | +20.91% |
| May. 24 | Barclays Adjusts Price Target on Alvotech to $22 From $20, Maintains Overweight Rating | MT |
| May. 22 | Transcript : Alvotech, Q1 2024 Earnings Call, May 22, 2024 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 3.9B | - | |||||
| 56.65B | - | |||||
| 39.44B | ||||||
| 39.03B | ||||||
| 26.86B | ||||||
| 26.75B |
- Stock Market
- Equities
- ALVO Stock
- Charts Alvotech
- Sector Chart
